These ETFs Might Enjoy the Salix Takeover News

Health care mergers and acquisitions is alive and well as confirmed by Valeant Pharmaceuticals (NYSE: VRX) acquisition of Salix Pharmaceuticals (NasdaqGS: SLXP) announced over the weekend. Canada-based Valeant, a habitual acquirer, will pay $10.1 billion, or $158 per share, for North Carolina-based...